In Vitro Antiviral Activity and Preclinical and Clinical Resistance Profile of Miravirsen, a Novel Anti-Hepatitis C Virus Therapeutic Targeting the Human Factor miR-122

导出原文传递

翻译打印收藏纠错

作者： Ottosen, Soren ^[1] ; Parsley, Todd B. ^[2] ; Yang, Lu ^[3] ; Zeh, Karin ^[4] ; van Doorn, Leen-Jan ; van der Veer, Eva ; Raney, Anneke K. ; Hodges, Michael R. ; Patick, Amy K.

作者单位： Santaris Pharma AS Corp, San Diego, CA 92130 USA ^[1] DDL Diagnost Lab, Voorburg, Netherlands ^[2] Santaris Pharma AS, Horsholm, Denmark ^[3] ImQuest BioSci, Frederick, MD USA ^[4]

发布时间 2015-11-05

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Antimicrobial agents and chemotherapy.

2015年59卷1期

599-608页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

In Vitro Antiviral Activity and Preclinical and Clinical Resistance Profile of Miravirsen, a Novel Anti-Hepatitis C Virus Therapeutic Targeting the Human Factor miR-122

Antimicrobial agents and chemotherapy.

相似文献

Antimicrobial agents and chemotherapy.

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

In Vitro Antiviral Activity and Preclinical and Clinical Resistance Profile of Miravirsen, a Novel Anti-Hepatitis C Virus Therapeutic Targeting the Human Factor miR-122

Antimicrobial agents and chemotherapy.

相似文献

Antimicrobial agents and chemotherapy.

相关期刊

检索历史清除